FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Inder Verma

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Cell Line

Procedures

Genetic Therapy

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Yasushi Soda; Chad Myskiw; Amy Rommel; Inder M Verma
Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.
Andrew J Holland; Erich A Nigg; Inder M Verma; Quan Zhu; Manuel Bauer; Daniele Fachinetti; Don W Cleveland
The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle.
Weiwei Yang; M James You; Lin Zhang; Yanhua Zheng; Inder M Verma; Yan Xia; Kenneth Aldape; Wen Bu; Yu Cao; Paul J Chiao; Gilbert Cote; Mei Yee Koh; Yi Li; Zhimin Lu
EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Inder Verma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yasushi Soda; Chad Myskiw; Amy Rommel; Inder M Verma
Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.
Journal of molecular medicine (Berlin, Germany) 2013;91(4):439-48.
2012: Andrew J Holland; Erich A Nigg; Inder M Verma; Quan Zhu; Manuel Bauer; Daniele Fachinetti; Don W Cleveland
The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle.
Genes & development 2012;26(24):2684-9.
2012: Weiwei Yang; M James You; Lin Zhang; Yanhua Zheng; Inder M Verma; Yan Xia; Kenneth Aldape; Wen Bu; Yu Cao; Paul J Chiao; Gilbert Cote; Mei Yee Koh; Yi Li; Zhimin Lu
EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Molecular cell 2012;48(5):771-84.
2012: Dinorah Friedmann-Morvinski; Eugene Ke; Tomotoshi Marumoto; Oded Singer; Yasushi Soda; Eric A Bushong; Mark H Ellisman; Inder M Verma
Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.
Science (New York, N.Y.) 2012;338(6110):1080-4.
2012: Inder M Verma
PNAS Plus: Refining a successful experiment.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(34):13469.
2012: Rajesh Narasimamurthy; Surendra K Nayak; Satchidananda Panda; Megumi Hatori; Fei Liu; Inder M Verma
Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(31):12662-7.
2012: Andrew J Holland; Mariana Lince-Faria; Nicole Parish; Inder M Verma; Benjamin Vitre; Quan Zhu; Monica Bettencourt-Dias; Denaly Chen; Sandrine Da Cruz; Daniele Fachinetti; Don W Cleveland
Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesis.
Molecular biology of the cell 2012;23(10):1838-45.
2012: Thales Papagiannakopoulos; David H Rowitch; Inder M Verma; H Zong; B A Barres; J C Dugas; Dinorah Friedmann-Morvinski; R M Gill; Emmanuelle Huillard; C Liu; P Neveu; Kenneth S Kosik
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.
Oncogene 2012;31(15):1884-95.
2012: Inder M Verma
Renato Dulbecco (1914-2012).
Nature 2012;483(7390):408.
2012: Fei Liu; Aaron S Parker; Yifeng Xia; Inder M Verma
IKK biology.
Immunological reviews 2012;246(1):239-53.
2012: Yifeng Xia; Narayana Yeddula; Yonghui Zhang; Eugene Ke; Mathias Leblanc; Eric Oldfield; Reuben J Shaw; Inder M Verma
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.
Nature cell biology 2012;14(3):257-65.
2011: Lilach Agemy; Dinorah Friedmann-Morvinski; Olivier M Girard; Venkata Ramana Kotamraju; Robert F Mattrey; Lise Roth; Kazuki N Sugahara; Inder M Verma; Erkki Ruoslahti
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(42):17450-5.
2011: Tatiana Hurtado de Mendoza; Todd T Kroll; Dennis D M O'Leary; Carlos G Perez-Garcia; Nien H Hoong; Inder M Verma
Antiapoptotic protein Lifeguard is required for survival and maintenance of Purkinje and granular cells.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(41):17189-94.
2011: Samantha H Murphy; Anthony P Orth; Kotaro Suzuki; Sumit K Chanda; Paul De Jesus; Michael Downes; Ronald M Evans; Loren Miraglia; Genevieve L Welch; Inder M Verma
Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(41):17117-22.
2011: Quan Zhu; Fred H Gage; Alexis M Huynh; petra nederlof; Gerald M Pao; Hoonkyo Suh; Nina Tonnu; Inder M Verma
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.
Nature 2011;477(7363):179-84.
2011: Niels-Bjarne Woods; Juan Carlos Izpisúa Belmonte; W Travis Berggren; Kristen J Brennand; Amy L Firth; Fred H Gage; Margaret K Lutz; Roksana Moraghebi; Aaron S Parker; Angel Raya; Inder M Verma
Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines.
Stem cells (Dayton, Ohio) 2011;29(7):1158-64.
2011: Vered Padler-Karavani; Nancy Hurtado-Ziola; Minya Pu; Hai Yu; Shengshu Huang; Saddam Muthana; Harshal A Chokhawala; Hongzhi Cao; Patrick Secrest; Dinorah Friedmann-Morvinski; Oded Singer; Darius Ghaderi; Inder M Verma; Yu-Tsueng Liu; Karen Messer; Xi Chen; Ajit Varki; Richard Schwab
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
Cancer research 2011;71(9):3352-63.
2011: Yasushi Soda; Tomotoshi Marumoto; Dinorah Friedmann-Morvinski; Mie Soda; Fei Liu; Hiroyuki Michiue; Sandra Pastorino; Meng Yang; Robert M Hoffman; Santosh Kesari; Inder M Verma
Transdifferentiation of glioblastoma cells into vascular endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(11):4274-80.
2011: Sergio Ruiz; Athanasia D Panopoulos; Aída Herrerías; Karl-Dimiter Bissig; Margaret Lutz; W Travis Berggren; Inder M Verma; Juan Carlos Izpisua-Belmonte
A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity.
Current biology : CB 2011;21(1):45-52.
2011: Kotaro Suzuki; Inder M Verma; Yifeng Xia; Masaya Yokota; Fei Liu; Samantha H Murphy; Daiki Nakagomi; Hiroshi Nakajima
Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation.
PloS one 2011;6(9):e25412.
2011: Tatiana Hurtado de Mendoza; Bartosz Balana; Paul A Slesinger; Inder M Verma
Organotypic cerebellar cultures: apoptotic challenges and detection.
Journal of visualized experiments : JoVE 2011;(51):.
2011: Brian Spencer; Robert Marr; Ryan Gindi; Rewati Potkar; Sarah Michael; Anthony Adame; Edward Rockenstein; Inder M Verma; Eliezer Masliah
Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease.
PloS one 2011;6(1):e16575.
2010: Annukka M Kivelä; Petri I Mäkinen; Henna-Kaisa Jyrkkänen; Eero Mella-Aho; Yifeng Xia; Emilia Kansanen; Hanna Leinonen; Inder M Verma; Seppo Ylä-Herttuala; Anna-Liisa Levonen
Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells.
Atherosclerosis 2010;213(1):122-8.
2010: Hsiangling Teo; Sourav Ghosh; Hendrik Luesch; Arkasubhra Ghosh; Ee-Tsin Wong; Najib Malik; Anthony Orth; Paul de Jesus; Anthony S Perry; Jeffrey D Oliver; Nhan L Tran; Lisa J Speiser; Marc Wong; Enrique Saez; Peter Schultz; Sumit K Chanda; Inder M Verma; Vinay Tergaonkar
Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression.
Nature cell biology 2010;12(8):758-67.
2010: Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.
The Journal of clinical investigation 2010;120(3):924-30.
2009: Zhongsheng You; Linda Z Shi; Quan Zhu; Peng Wu; You-Wei Zhang; Andrew Basilio; Nina Tonnu; Inder M Verma; Michael W Berns; Tony Hunter
CtIP links DNA double-strand break sensing to resection.
Molecular cell 2009;36(6):954-69.
2009: Maziyar Saberi; Niels-Bjarne Woods; Carl de Luca; Simon Schenk; Juu-Chin Lu; Gautam Bandyopadhyay; Inder M Verma; Jerrold M Olefsky
Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice.
Cell metabolism 2009;10(5):419-29.
2009: Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan A. Bueren; Juan Carlos Izpisúa Belmonte
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.
Nature 2009;460(7251):53-9.
2009: Yifeng Xia; Roanna C Padre; Tatiana Hurtado De Mendoza; Virginie Bottero; Vinay B Tergaonkar; Inder M Verma
Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(8):2629-34.
2009: Jeramiah J Smith; Srikrishna Putta; Wei Zhu; Gerald M Pao; Inder M Verma; Tony Hunter; Susan V Bryant; David M Gardiner; Timothy T Harkins; S Randal Voss
Genic regions of a large salamander genome contain long introns and novel genes.
BMC genomics 2009;10():19.
2009: james monaghan; Leonard G Epp; Srikrishna Putta; Robert B Page; John A Walker; Chris K Beachy; Wei Zhu; Gerald M Pao; Inder M Verma; Tony Hunter; Susan V Bryant; David M Gardiner; Tim T Harkins; S Randal Voss
Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration.
BMC biology 2009;7():1.
2009: Tomotoshi Marumoto; Ayumu Tashiro; Dinorah Friedmann-Morvinski; Miriam Scadeng; Yasushi Soda; Fred H Gage; Inder M Verma
Development of a novel mouse glioma model using lentiviral vectors.
Nature medicine 2009;15(1):110-6.
2008: Oded Singer; Inder M Verma
Applications of lentiviral vectors for shRNA delivery and transgenesis.
Current gene therapy 2008;8(6):483-8.
2008: Kotaro Suzuki; Inder M Verma
Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation.
Cell 2008;134(3):485-95.
2008: Salim S El-Amouri; Hong Zhu; Jin Yu; Robert Marr; Inder M Verma; Mark S Kindy
Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.
The American journal of pathology 2008;172(5):1342-54.
2008: Gustavo Tiscornia; Oded Singer; Inder M Verma
Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version B.
CSH protocols 2008;2008():pdb.prot5010.
2008: Gustavo Tiscornia; Oded Singer; Inder M Verma
Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version A.
CSH protocols 2008;2008():pdb.prot5009.
2008: Brian Spencer; Robert Marr; Edward Rockenstein; Leslie Crews; Anthony Adame; Rewati Potkar; Christina Patrick; Fred H Gage; Inder M Verma; Eliezer Masliah
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.
BMC neuroscience 2008;9():109.
2007: Jami McLaughlin; Donghui Cheng; Oded Singer; Rita U Lukacs; Caius G Radu; Inder M Verma; Owen N Witte
Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(51):20501-6.
2007: Sandhya R Pulivarthy; Nobushige Tanaka; David K Welsh; Luciano De Haro; Inder M Verma; Satchidananda Panda
Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(51):20356-61.
2007: Karl-Dimiter Bissig; Tam T Le; Niels-Bjarne Woods; Inder M Verma
Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(51):20507-11.
2007: Jeffrey T Irelan; Thomas J Murphy; Paul D DeJesus; Hsiangling Teo; Dingyue Xu; Maria A Gomez-Ferreria; Yingyao Zhou; Loren Miraglia; Daniel R Rines; Inder M Verma; David J Sharp; Vinay Tergaonkar; Sumit K Chanda
A role for IkappaB kinase 2 in bipolar spindle assembly.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(43):16940-5.
2007: Wei Liao; M T Audrey Nguyen; Takeshi Yoshizaki; Svetlana Favelyukis; David Patsouris; Takeshi Imamura; Inder M Verma; Jerrold M Olefsky
Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.
American journal of physiology. Endocrinology and metabolism 2007;293(1):E219-27.
2007: Mieczyslaw Michalkiewicz; Teresa Michalkiewicz; Aron M Geurts; Richard J Roman; Glenn R Slocum; Oded Singer; Dorothee Weihrauch; Andrew S Greene; Mary L Kaldunski; Inder M Verma; Howard J Jacob; Allen W Cowley
Efficient transgenic rat production by a lentiviral vector.
American journal of physiology. Heart and circulatory physiology 2007;293(1):H881-94.
2007: Salim S El-Amouri; Hong Zhu; Jin Yu; Fred H Gage; Inder M Verma; Mark S Kindy
Neprilysin protects neurons against Abeta peptide toxicity.
Brain research 2007;1152():191-200.
2007: Andrew C Liu; David K Welsh; Caroline Ko; Hien G Tran; Eric Erquan Zhang; Aaron A Priest; Ethan D Buhr; Oded Singer; Kirsten Meeker; Inder M Verma; Francis J Doyle; Joseph S Takahashi; Steve A Kay
Intercellular coupling confers robustness against mutations in the SCN circadian clock network.
Cell 2007;129(3):605-16.
2007: Brian J Spencer; Inder M Verma
Targeted delivery of proteins across the blood-brain barrier.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(18):7594-9.
2007: Alexander Hoffmann; Yifeng Xia; Inder M Verma
Inflammatory tales of liver cancer.
Cancer cell 2007;11(2):99-101.
2007: Soumen Basak; Hana Kim; Jeffrey D Kearns; Vinay Tergaonkar; Ellen O'Dea; Shannon L Werner; Chris A Benedict; Carl Ware; riya ghosh; Inder M Verma; Alexander Hoffmann
A fourth IkappaB protein within the NF-kappaB signaling module.
Cell 2007;128(2):369-81.
2007: Oded Singer; Gustavo Tiscornia; Inder M Verma
Knockdown transgenic mice generated by silencing lentiviral vectors: zona pellucida removal and subzonal injection methods.
CSH protocols 2007;2007():pdb.prot4756.
2006: Sourav Ghosh; Vinay Tergaonkar; Carla V Rothlin; Ricardo G Correa; Virginie Bottero; Pradeep Bist; Inder M Verma; Tony Hunter
Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.
Cancer cell 2006;10(3):215-26.
2006: Virginie Bottero; Sebo Withoff; Inder M Verma
NF-kappaB and the regulation of hematopoiesis.
Cell death and differentiation 2006;13(5):785-97.
2006: Wei Liao; M T Audrey Nguyen; Takeshi Imamura; Oded Singer; Inder M Verma; Jerrold M Olefsky
Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes.
Endocrinology 2006;147(5):2245-52.
2006: Niels-Bjarne Woods; Virginie Bottero; Manfred Schmidt; Christof von Kalle; Inder M Verma
Gene therapy: therapeutic gene causing lymphoma.
Nature 2006;440(7088):1123.
2006: Nobushige Tanaka; Masahito Ikawa; Nathan L Mata; Inder M Verma
Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;13(3):609-16.
2006: Oded Singer; Gustavo Tiscornia; Masahito Ikawa; Inder M Verma
Rapid generation of knockdown transgenic mice by silencing lentiviral vectors.
Nature protocols 2006;1(1):286-92.
2006: Gustavo Tiscornia; Oded Singer; Inder M Verma
Production and purification of lentiviral vectors.
Nature protocols 2006;1(1):241-5.
2006: Gustavo Tiscornia; Oded Singer; Inder M Verma
Design and cloning of lentiviral vectors expressing small interfering RNAs.
Nature protocols 2006;1(1):234-40.
2005: Jyotsna Dhawan; Rajesh S Gokhale; Inder M Verma
Bioscience in India: times are changing.
Cell 2005;123(5):743-5.
2005: Iiris Hovatta; Richard S Tennant; Robert Helton; Robert Marr; Oded Singer; Jeffrey M Redwine; Julie A Ellison; Eric E Schadt; Inder M Verma; David J Lockhart; Carrolee Barlow
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice.
Nature 2005;438(7068):662-6.
2005: Qiutang Li; Qingxian Lu; Gabriela Estepa; Inder M Verma
Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(44):15977-82.
2005: Inder M Verma
From one experiment to the next.
BioTechniques 2005;39(4):443.
2005: Oded Singer; Robert Marr; Edward Rockenstein; Leslie Crews; Nicole G Coufal; Fred H Gage; Inder M Verma; Eliezer Masliah
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.
Nature neuroscience 2005;8(10):1343-9.
2005: Vinay Tergaonkar; Ricardo G Correa; Masahito Ikawa; Inder M Verma
Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.
Nature cell biology 2005;7(9):921-3.
2005: Qiutang Li; Qingxian Lu; Virginie Bottero; Gabriela Estepa; Lisa Morrison; Frank Mercurio; Inder M Verma
Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).
Proceedings of the National Academy of Sciences of the United States of America 2005;102(35):12425-30.
2005: Inder M Verma
Then and now.
Nature 2005;436(7050):478-9.
2005: Ricardo G Correa; Takaaki Matsui; Vinay Tergaonkar; Concepcion Rodriguez-Esteban; Juan Carlos Izpisua-Belmonte; Inder M Verma
Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity.
Current biology : CB 2005;15(14):1291-5.
2005: Armin Blesch; James Conner; Alexander Pfeifer; Mehdi Gasmi; Anthony Ramirez; William Britton; Ron Alfa; Inder M Verma; Mark H Tuszynski
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(6):916-25.
2005: Qiutang Li; Sebo Withoff; Inder M Verma
Inflammation-associated cancer: NF-kappaB is the lynchpin.
Trends in immunology 2005;26(6):318-25.
2005: Inder M Verma
Interview with Dr Verma.
Gene therapy 2005;12(12):950-3.
2005: Lili Wang; Roberto Calcedo; Timothy C Nichols; Dwight A Bellinger; Aaron Dillow; Inder M Verma; James M Wilson
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy.
Blood 2005;105(8):3079-86.
2005: Francesco Galimi; Robert G Summers; Henriette van Praag; Inder M Verma; Fred H Gage
A role for bone marrow-derived cells in the vasculature of noninjured CNS.
Blood 2005;105(6):2400-2.
2005: Jean-Cosme Dodart; Robert Marr; Milla Koistinaho; Beth M Gregersen; Seema Malkani; Inder M Verma; Steven M Paul
Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(4):1211-6.
2005: Inder M Verma; Matthew D Weitzman
Gene therapy: twenty-first century medicine.
Annual review of biochemistry 2005;74():711-38.
2005: Francesco Galimi; Enrique Saez; Jason Gall; Nien Hoong; Gerald Cho; Ronald M Evans; Inder M Verma
Development of ecdysone-regulated lentiviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(1):142-8.
2004: Inder M Verma
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
Annals of the rheumatic diseases 2004;63 Suppl 2():ii57-ii61.
2004: Christopher P Austin; James F Battey; Allan Bradley; Maja Bucan; Mario R Capecchi; Francis S Collins; William F Dove; Geoffrey Duyk; Susan Dymecki; Janan T Eppig; Franziska B Grieder; Nathaniel Heintz; Geoff Hicks; Thomas R Insel; Alexandra L Joyner; Beverly H Koller; K C Kent Lloyd; Terry Magnuson; Mark W Moore; Andras Nagy; Jonathan D Pollock; Allen D Roses; Arthur T Sands; Brian Seed; William C Skarnes; Jay Snoddy; Philippe Soriano; David J Stewart; Francis Stewart; Bruce Stillman; Harold Varmus; Lyuba Varticovski; Inder M Verma; Thomas F Vogt; Harald von Melchner; Jan Witkowski; Richard P Woychik; Wolfgang Wurst; George D Yancopoulos; Stephen G Young; Brian Zambrowicz
The knockout mouse project.
Nature genetics 2004;36(9):921-4.
2004: Inder M Verma
Doping, gene transfer and sport.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(3):405.
2004: Inder M Verma
Musings for young scientists.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(2):201.
2004: Inder M Verma
Agbiotech: success depends on trust.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(1):1.
2004: Jeanette L Ducut Sigala; Virginie Bottero; David B Young; Andrej Shevchenko; Frank Mercurio; Inder M Verma
Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit.
Science (New York, N.Y.) 2004;304(5679):1963-7.
2004: Inder M Verma
Visa crisis hurts U.S. science.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(6):767.
2004: Ricardo G Correa; Vinay Tergaonkar; Jennifer K Ng; Ilir Dubova; Juan Carlos Izpisua-Belmonte; Inder M Verma
Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development.
Molecular and cellular biology 2004;24(12):5257-68.
2004: Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
CRE recombinase-inducible RNA interference mediated by lentiviral vectors.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(19):7347-51.
2004: Inder M Verma
Stem cell politics get dirty.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(5):633.
2004: Oded Singer; Amiel Yanai; Inder M Verma
Silence of the genes.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(15):5313-4.
2004: Hanna Kankkonen; Elisa Vähäkangas; Robert Marr; Timo Pakkanen; Anniina Laurema; Pia Leppänen; Johanna Jalkanen; Inder M Verma; Seppo Ylä-Herttuala
Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(4):548-56.
2004: Inder M Verma
AIDS: no end in sight.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(2):141.
2004: Robert Marr; Guan Hanjun; Edward Rockenstein; Mark S Kindy; Fred H Gage; Inder M Verma; Eliezer Masliah; Louis B Hersh
Neprilysin regulates amyloid Beta peptide levels.
Journal of molecular neuroscience : MN 2004;22(1-2):5-11.
2003: Vinay Tergaonkar; Virginie Bottero; Masahito Ikawa; Qiutang Li; Inder M Verma
IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
Molecular and cellular biology 2003;23(22):8070-83.
2003: Kazuaki Takabe; Lili Wang; Angela M O Leal; Leigh A MacConell; Ezra Wiater; Tomoaki Tomiya; Akihiko Ohno; Inder M Verma; Wylie Vale
Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats.
Hepatology (Baltimore, Md.) 2003;38(5):1107-15.
2003: Inder M Verma
Fraud and deception in science.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(4):519.
2003: Masahito Ikawa; Nobushige Tanaka; Winston W-Y Kao; Inder M Verma
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(4):666-73.
2003: Yoshiyuki Kanazawa; Inder M Verma
Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver.
Proceedings of the National Academy of Sciences of the United States of America 2003;100 Suppl 1():11850-3.
2003: Fred H Gage; Inder M Verma
Stem cells at the dawn of the 21st century.
Proceedings of the National Academy of Sciences of the United States of America 2003;100 Suppl 1():11817-8.
2003: Inder M Verma
Illiteracy, ignorance, intolerance=terrorism.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(1):1.
2003: Sook Shin; Inder M Verma
BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(12):7201-6.
2003: Inder M Verma
SARS: fear of global pandemic.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(6):711.
2003: Inder M Verma
Good-bye Dolly.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(5 Pt 1):565.
2003: Neeltje Kootstra; Ryusuke Matsumura; Inder M Verma
Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(5 Pt 1):623-31.
2003: Inder M Verma
The DNA helix at 50.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(4):427.
2003: Robert Marr; Edward Rockenstein; Atish Mukherjee; Mark S Kindy; Louis B Hersh; Fred H Gage; Inder M Verma; Eliezer Masliah
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(6):1992-6.
2003: Gustavo Tiscornia; Oded Singer; Masahito Ikawa; Inder M Verma
A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(4):1844-8.
2003: Yan Xia; Gerald M Pao; Hongwu Chen; Inder M Verma; Tony Hunter
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
The Journal of biological chemistry 2003;278(7):5255-63.
2003: Neeltje Kootstra; Carsten Munk; Nina Tonnu; Nathaniel R Landau; Inder M Verma
Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(3):1298-303.
2003: Inder M Verma
A voluntary moratorium?
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(2):141.
2003: Neeltje Kootstra; Inder M Verma
Gene therapy with viral vectors.
Annual review of pharmacology and toxicology 2003;43():413-39.
2002: Inder M Verma
2002 Nobel Prize for physiology and medicine.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(6):698.
2002: Inder M Verma
Making the promise a reality.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(6):695.
2002: Inder M Verma
Success and setback: another adverse event.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(5):565-6.
2002: Francesco Galimi; Meenakshi Noll; Yoshiyuki Kanazawa; Timothy Lax; Cindy Chen; Markus Grompe; Inder M Verma
Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
Blood 2002;100(8):2732-6.
2002: Inder M Verma
Politics and scientific publishing: noli me tangere.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(4):431.
2002: Qiutang Li; Inder M Verma
NF-kappaB regulation in the immune system.
Nature reviews. Immunology 2002;2(10):725-34.
2002: Tippi C Mackenzie; Gary P Kobinger; Neeltje Kootstra; Antoneta Radu; Miguel Sena-Esteves; Sarah Bouchard; James M Wilson; Inder M Verma; Alan W Flake
Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(3):349-58.
2002: Dao Pan; Roland Gunther; Weiming Duan; Steve Wendell; William Kaemmerer; Tal Kafri; Inder M Verma; Chester Whitley
Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(1):19-29.
2002: Inder M Verma
Hypothesis-driven science.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(1):1.
2002: Vinay Tergaonkar; Matthew Pando; Omid Vafa; Geoffrey M Wahl; Inder M Verma
p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy.
Cancer cell 2002;1(5):493-503.
2002: Inder M Verma
Do not ban therapeutic cloning.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(6):651.
2002: Masahito Ikawa; Vinay Tergaonkar; Atsuo Ogura; Narumi Ogonuki; Kimiko Inoue; Inder M Verma
Restoration of spermatogenesis by lentiviral gene transfer: offspring from infertile mice.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(11):7524-9.
2002: Inder M Verma
Politics and AIDS: a bad mix.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(5 Pt 1):485.
2002: Inder M Verma
Censorship of scientific publications: a bad idea.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(4):337.
2002: Inder M Verma
A gene therapy institute for NIH?
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(3):213.
2002: Angela M O Leal; Kazuaki Takabe; Lili Wang; Cynthia J Donaldson; Leigh A MacConell; Louise M Bilezikjian; Inder M Verma; Wylie Vale
Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo.
Endocrinology 2002;143(3):964-9.
2002: Alexander Pfeifer; Masahito Ikawa; Yelena Dayn; Inder M Verma
Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(4):2140-5.
2002: Brian K Kaspar; Bryce Vissel; Tasha Bengoechea; Steven Crone; Lynne Randolph-Moore; Rolf Muller; Eugene Brandon; David V Schaffer; Inder M Verma; Kuo-Fen Lee; Stephen F Heinemann; Fred H Gage
Adeno-associated virus effectively mediates conditional gene modification in the brain.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(4):2320-5.
2002: Inder M Verma
Biopiracy: distrust widens the rich-poor divide.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(2):95.
2002: Torsten Kessler; A Pfeifer; Steven A. Silletti; Rolf M Mesters; Wolfgang E Berdel; Inder M Verma; David A Cheresh
Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.
Annals of hematology 2002;81 Suppl 2():S69-70.
2002: Francesco Galimi; Inder M Verma
Opportunities for the use of lentiviral vectors in human gene therapy.
Current topics in microbiology and immunology 2002;261():245-54.
2001: C Lamberti; Keng-Mean Lin; Yumi Yamamoto; Udit N Verma; Inder M Verma; Stephen W Byers; Richard B Gaynor
Regulation of beta-catenin function by the IkappaB kinases.
The Journal of biological chemistry 2001;276(45):42276-86.
2001: Inder M Verma
Gene therapy and jurisprudence.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(5):393.
2001: A Pfeifer; Eugene Brandon; Neeltje Kootstra; F H Gage; Inder M Verma
Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(20):11450-5.
2001: Inder M Verma
Are the benefits of stem cells being oversold?
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(3):161.
2001: Linda M McAllister-Lucas; Naohiro Inohara; Peter C Lucas; Jürgen Ruland; Adalberto Benito; Quanwen Li; Shiming Chen; Felicia F Chen; Shoji Yamaoka; Inder M Verma; Tak W Mak; Gabriel Núñez
Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction.
The Journal of biological chemistry 2001;276(33):30589-97.
2001: Inder M Verma
Adverse event reporting: essential for science and public trust.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(2):83.
2001: Inder M Verma
Germline gene therapy: yes or no?
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(1):1.
2001: Inder M Verma
Ombudsman or hotline for Gene therapy clinical trials?
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(6):817-8.
2001: Inder M Verma
Stem cell research: win, win, win by keeping politics out.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(5 Pt 1):641.
2001: H Ruffner; Claudio A P Joazeiro; D Hemmati; Tony Hunter; Inder M Verma
Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(9):5134-9.
2001: Inder M Verma
Pharma + profits = continued aids epidemic.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(4):419.
2001: A Pfeifer; T Kessler; M Yang; E Baranov; Neeltje Kootstra; David A Cheresh; R M Hoffman; Inder M Verma
Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(3):319-22.
2001: A Pfeifer; Inder M Verma
Gene therapy: promises and problems.
Annual review of genomics and human genetics 2001;2():177-211.
2001: K Xu; Hong Ma; Thomas J McCown; Inder M Verma; Tal Kafri
Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(1):97-104.
2000: Inder M Verma
Gene therapy: the need for basic science.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(6):531.
2000: N Somia; Inder M Verma
Gene therapy: trials and tribulations.
Nature reviews. Genetics 2000;1(2):91-9.
2000: Inder M Verma
A tumultuous year for gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(5):415-6.
2000: A Pfeifer; Torsten Kessler; Steven A. Silletti; David A Cheresh; Inder M Verma
Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12227-32.
2000: Inder M Verma
AIDS: are we doing enough?
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(4):299.
2000: Inder M Verma
Gene therapy: public education.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(3):177.
2000: Inder M Verma; F H Gage
Genome and gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(2):95.
2000: Q Li; G Estepa; S Memet; Alain Israel; Inder M Verma
Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.
Genes & development 2000;14(14):1729-33.
2000: M P Pando; Inder M Verma
Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha.
The Journal of biological chemistry 2000;275(28):21278-86.
2000: Tal Kafri; H van Praag; Fred H Gage; Inder M Verma
Lentiviral vectors: regulated gene expression.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(6):516-21.
2000: Inder M Verma
Gene therapy: beyond 2000.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(6):493.
2000: NV Somia; H Miyoshi; M J Schmitt; Inder M Verma
Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping.
Journal of virology 2000;74(9):4420-4.
2000: L Wang; Timothy C Nichols; Marjorie S Read; Dwight A Bellinger; Inder M Verma
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(2):154-8.
2000: G M Pao; R Janknecht; H Ruffner; Tony Hunter; Inder M Verma
CBP/p300 interact with and function as transcriptional coactivators of BRCA1.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(3):1020-5.
2000: Tsuyoshi Miyazaki; H Katagiri; Yumi Kanegae; Hiroshi Takayanagi; Y Sawada; Aiichiro Yamamoto; Matthew Pando; Tomoichiro Asano; Inder M Verma; Hiromi Oda; Kozo Nakamura; Sakae Tanaka
Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts.
The Journal of cell biology 2000;148(2):333-42.
2000: Luigi Naldini; Inder M Verma
Lentiviral vectors.
Advances in virus research 2000;55():599-609.
1999: B H Spain; C J Larson; LS Shihabuddin; Fred H Gage; Inder M Verma
Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):13920-5.
1999: NV Somia; M J Schmitt; Douglas Vetter; DJ Van Antwerp; Stephen F Heinemann; Inder M Verma
LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(22):12667-72.
1999: M Takahashi; H Miyoshi; Inder M Verma; Fred H Gage
Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer.
Journal of virology 1999;73(9):7812-6.
1999: H Ruffner; W Jiang; A G Craig; Tony Hunter; Inder M Verma
BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.
Molecular and cellular biology 1999;19(7):4843-54.
1999: Q Li; Q Lu; J Y Hwang; Dirk Büscher; K F Lee; J C Izpisua-Belmonte; Inder M Verma
IKK1-deficient mice exhibit abnormal development of skin and skeleton.
Genes & development 1999;13(10):1322-8.
1999: Q Li; D Van Antwerp; F Mercurio; K F Lee; Inder M Verma
Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.
Science (New York, N.Y.) 1999;284(5412):321-5.
1999: L Wang; K Takabe; S M Bidlingmaier; CR Ill; Inder M Verma
Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):3906-10.
1999: N V Somia; Tal Kafri; Inder M Verma
Piecing together more efficient gene expression.
Nature biotechnology 1999;17(3):224-5.
1999: H Miyoshi; K A Smith; D E Mosier; Inder M Verma; B E Torbett
Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.
Science (New York, N.Y.) 1999;283(5402):682-6.
1999: Inder M Verma
From reverse transcriptase to gene therapy: a marvelous journey.
Harvey lectures 1999;95():43-66.
1999: Tal Kafri; H van Praag; L Ouyang; Fred H Gage; Inder M Verma
A packaging cell line for lentivirus vectors.
Journal of virology 1999;73(1):576-84.
1998: W S Gallichan; Tal Kafri; Troy Krahl; Inder M Verma; Nora Sarvetnick
Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis.
Human gene therapy 1998;9(18):2717-26.
1998: H Miyoshi; U Blömer; M Takahashi; Fred H Gage; Inder M Verma
Development of a self-inactivating lentivirus vector.
Journal of virology 1998;72(10):8150-7.
1998: Tal Kafri; D Morgan; Troy Krahl; Nora Sarvetnick; L Sherman; Inder M Verma
Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(19):11377-82.
1998: E M Schwarz; Cornel Badorff; T S Hiura; Rainer Wessely; A Badorff; Inder M Verma; Kirk U Knowlton
NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice.
Journal of virology 1998;72(7):5654-60.
1998: Yumi Kanegae; AT Tavares; Juan Carlos Izpisúa Belmonte; Inder M Verma
Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb.
Nature 1998;392(6676):611-4.
1998: U Blömer; Tal Kafri; L Randolph-Moore; Inder M Verma; Fred H Gage
Bcl-xL protects adult septal cholinergic neurons from axotomized cell death.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(5):2603-8.
1998: DJ Van Antwerp; Seamus Martin; Inder M Verma; D R Green
Inhibition of TNF-induced apoptosis by NF-kappa B.
Trends in cell biology 1998;8(3):107-11.
1997: Tal Kafri; U Blömer; D A Peterson; Fred H Gage; Inder M Verma
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Nature genetics 1997;17(3):314-7.
1997: Inder M Verma; J Stevenson
IkappaB kinase: beginning, not the end.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(22):11758-60.
1997: L Wang; M Zoppè; T M Hackeng; J H Griffin; K F Lee; Inder M Verma
A factor IX-deficient mouse model for hemophilia B gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11563-6.
1997: Inder M Verma; N Somia
Gene therapy -- promises, problems and prospects.
Nature 1997;389(6648):239-42.
1997: H Miyoshi; M Takahashi; Fred H Gage; Inder M Verma
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(19):10319-23.
1997: U Blömer; L Naldini; Tal Kafri; D Trono; Inder M Verma; Fred H Gage
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector.
Journal of virology 1997;71(9):6641-9.
1997: K Tashiro; Matthew Pando; Yumi Kanegae; P M Wamsley; S Inoue; Inder M Verma
Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalpha.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):7862-7.
1997: H Ruffner; Inder M Verma
BRCA1 is a cell cycle-regulated nuclear phosphoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7138-43.
1997: M L Carrozza; Heinz Jacobs; D Acton; Inder M Verma; Anton Berns
Overexpression of the FosB2 gene in thymocytes causes aberrant development of T cells and thymic epithelial cells.
Oncogene 1997;14(9):1083-91.
1997: E M Schwarz; Paul Krimpenfort; Anton Berns; Inder M Verma
Immunological defects in mice with a targeted disruption in Bcl-3.
Genes & development 1997;11(2):187-97.
1996: D J Van Antwerp; Inder M Verma
Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
Molecular and cellular biology 1996;16(11):6037-45.
1996: D J Van Antwerp; Seamus Martin; Tal Kafri; D R Green; Inder M Verma
Suppression of TNF-alpha-induced apoptosis by NF-kappaB.
Science (New York, N.Y.) 1996;274(5288):787-9.
1996: Luigi Naldini; U Blömer; Fred H Gage; Didier Trono; Inder M Verma
Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11382-8.
1996: M S Chapman; Inder M Verma
Transcriptional activation by BRCA1.
Nature 1996;382(6593):678-9.
1996: R K Naviaux; E Costanzi; M Haas; Inder M Verma
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.
Journal of virology 1996;70(8):5701-5.
1996: E M Schwarz; D Van Antwerp; Inder M Verma
Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha.
Molecular and cellular biology 1996;16(7):3554-9.
1996: Inder M Verma
"Green light" for gene transfer.
Nature biotechnology 1996;14(5):576.
1996: Luigi Naldini; U Blömer; P Gallay; D Ory; R Mulligan; Fred H Gage; Inder M Verma; Didier Trono
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
Science (New York, N.Y.) 1996;272(5259):263-7.
1996: U Blömer; Luigi Naldini; Inder M Verma; Didier Trono; Fred H Gage
Applications of gene therapy to the CNS.
Human molecular genetics 1996;5 Spec No():1397-404.
1995: Inder M Verma; J K Stevenson; E M Schwarz; D Van Antwerp; shigeki miyamoto
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Genes & development 1995;9(22):2723-35.
1995: C F Barroga; J K Stevenson; E M Schwarz; Inder M Verma
Constitutive phosphorylation of I kappa B alpha by casein kinase II.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(17):7637-41.
1995: N V Somia; M Zoppé; Inder M Verma
Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(16):7570-4.
1995: Y Dai; E M Schwarz; D Gu; W W Zhang; N Sarvetnick; Inder M Verma
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(5):1401-5.
1995: shigeki miyamoto; K Cauley; Inder M Verma
Ultraviolet cross-linking of DNA binding proteins.
Methods in enzymology 1995;254():632-41.
1995: shigeki miyamoto; Inder M Verma
Rel/NF-kappa B/I kappa B story.
Advances in cancer research 1995;66():255-92.
1994: shigeki miyamoto; M Maki; M J Schmitt; M Hatanaka; Inder M Verma
Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):12740-4.
1994: Inder M Verma
Gene therapy: hopes, hypes, and hurdles.
Molecular medicine (Cambridge, Mass.) 1994;1(1):2-3.
1994: C F Stevens; Inder M Verma
Memory. A model with good CREdentials.
Current biology : CB 1994;4(8):736-8.
1994: E Bengal; O Flores; P N Rangarajan; A Chen; H Weintraub; Inder M Verma
Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(13):6221-5.
1994: shigeki miyamoto; M J Schmitt; Inder M Verma
Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(11):5056-60.
1994: shigeki miyamoto; P J Chiao; Inder M Verma
Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.
Molecular and cellular biology 1994;14(5):3276-82.
1994: K Cauley; Inder M Verma
Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(1):390-4.
1994: P J Chiao; shigeki miyamoto; Inder M Verma
Autoregulation of I kappa B alpha activity.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(1):28-32.
1993: R Wisdon; Inder M Verma
Transformation by Fos proteins requires a C-terminal transactivation domain.
Molecular and cellular biology 1993;13(12):7429-38.
1993: Gary Nabel; Inder M Verma
Proposed NF-kappa B/I kappa B family nomenclature.
Genes & development 1993;7(11):2063.
1993: L D Kerr; L J Ransone; P Wamsley; M J Schmitt; Thomas Boyer; Q Zhou; A J Berk; Inder M Verma
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.
Nature 1993;365(6445):412-9.
1993: M Polak; R Scharfmann; B Seilheimer; George S Eisenbarth; D Dressler; Inder M Verma; H Potter
Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(12):5781-5.
1993: R Wisdom; Inder M Verma
Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation.
Molecular and cellular biology 1993;13(5):2635-43.
1993: T Léveillard; Inder M Verma
Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins.
Gene expression 1993;3(2):135-50.
1993: L J Ransone; L D Kerr; M J Schmitt; P Wamsley; Inder M Verma
The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.
Gene expression 1993;3(1):37-48.
1993: V J Dwarki; R W Malone; Inder M Verma
Cationic liposome-mediated RNA transfection.
Methods in enzymology 1993;217():644-54.
1992: L D Kerr; Colin S Duckett; P Wamsley; Q Zhang; P Chiao; Gary Nabel; T W McKeithan; P A Baeuerle; Inder M Verma
The proto-oncogene bcl-3 encodes an I kappa B protein.
Genes & development 1992;6(12A):2352-63.
1992: Y Dai; Mark Roman; R K Naviaux; Inder M Verma
Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):10892-5.
1992: R K Naviaux; Inder M Verma
Retroviral vectors for persistent expression in vivo.
Current opinion in biotechnology 1992;3(5):540-7.
1992: B A Naughton; Y Dai; B Sibanda; R Scharfmann; J San Roman; F Zeigler; Inder M Verma
Long-term expression of a retrovirally introduced beta-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes.
Somatic cell and molecular genetics 1992;18(5):451-62.
1992: I M Morgan; L J Ransone; T J Bos; Inder M Verma; Peter K Vogt
Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Oncogene 1992;7(6):1119-25.
1992: L D Kerr; J Inoue; Inder M Verma
Signal transduction: the nuclear target.
Current opinion in cell biology 1992;4(3):496-501.
1992: J Inoue; L D Kerr; D Rashid; James Davis; H R Bose; Inder M Verma
Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(10):4333-7.
1992: Mark Roman; J H Axelrod; Y Dai; R K Naviaux; Theodore Friedmann; Inder M Verma
Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle.
Somatic cell and molecular genetics 1992;18(3):247-58.
1992: R Wisdom; J Yen; D Rashid; Inder M Verma
Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains.
Genes & development 1992;6(4):667-75.
1992: J Inoue; L D Kerr; A Kakizuka; Inder M Verma
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family.
Cell 1992;68(6):1109-20.
1992: I Tratner; Rivka Ofir; Inder M Verma
Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential.
Molecular and cellular biology 1992;12(3):998-1006.
1992: Atsushi Miyanohara; P A Johnson; R L Elam; Y Dai; Joseph L Witztum; Inder M Verma; Theodore Friedmann
Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX.
The New biologist 1992;4(3):238-46.
1992: Eyal Bengal; L Ransone; R Scharfmann; V J Dwarki; Stephen J Tapscott; H Weintraub; Inder M Verma
Functional antagonism between c-Jun and MyoD proteins: a direct physical association.
Cell 1992;68(3):507-19.
1992: Inder M Verma; J Inoue; L D Kerr; Rivka Ofir; L J Ransone
Oncogenes as transcription factors:implications for signal transduction.
Progress in clinical and biological research 1992;376():41-59.
1991: I Tratner; Inder M Verma
Identification of a nuclear targeting sequence in the Fos protein.
Oncogene 1991;6(11):2049-53.
1991: L D Kerr; J Inoue; James Davis; E Link; P A Baeuerle; H R Bose; Inder M Verma
The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
Genes & development 1991;5(8):1464-76.
1991: R Schüle; P Rangarajan; N Yang; Steven A Kliewer; L J Ransone; J Bolado; Inder M Verma; Ronald M Evans
Retinoic acid is a negative regulator of AP-1-responsive genes.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(14):6092-6.
1991: J Yen; R M Wisdom; I Tratner; Inder M Verma
An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(12):5077-81.
1991: R Scharfmann; J H Axelrod; Inder M Verma
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(11):4626-30.
1991: Inder M Verma; R K Naviaux
Human gene therapy.
Current opinion in genetics & development 1991;1(1):54-9.
1991: J Inoue; L D Kerr; L J Ransone; Eyal Bengal; Tony Hunter; Inder M Verma
c-rel activates but v-rel suppresses transcription from kappa B sites.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(9):3715-9.
1991: Rivka Ofir; V J Dwarki; D Rashid; Inder M Verma
CREB represses transcription of fos promoter: role of phosphorylation.
Gene expression 1991;1(1):55-60.
1990: Inder M Verma
Gene therapy.
Scientific American 1990;263(5):68-72, 81-4.
1990: R Wisdom; Inder M Verma
Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant.
Molecular and cellular biology 1990;10(11):5626-33.
1990: Rivka Ofir; V J Dwarki; D Rashid; Inder M Verma
Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter.
Nature 1990;348(6296):80-2.
1990: P Bull; K L Morley; MF Hoekstra; Tony Hunter; Inder M Verma
The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain.
Molecular and cellular biology 1990;10(10):5473-85.
1990: R Schüle; P Rangarajan; Steven A Kliewer; L J Ransone; J Bolado; N Yang; Inder M Verma; Ronald M Evans
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.
Cell 1990;62(6):1217-26.
1990: L J Ransone; P Wamsley; K L Morley; Inder M Verma
Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins.
Molecular and cellular biology 1990;10(9):4565-73.
1990: J H Axelrod; Marjorie S Read; Kenneth Brinkhous; Inder M Verma
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(13):5173-7.
1990: C L Li; V J Dwarki; Inder M Verma
Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4349-53.
1990: W W Lamph; V J Dwarki; Rivka Ofir; M Montminy; Inder M Verma
Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4320-4.
1990: L J Ransone; J Visvader; P Wamsley; Inder M Verma
Trans-dominant negative mutants of Fos and Jun.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3806-10.
1990: Lionel B Ivashkiv; H C Liou; C J Kara; W W Lamph; Inder M Verma; Laurie H Glimcher
mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element.
Molecular and cellular biology 1990;10(4):1609-21.
1990: Paolo Sassone-Corsi; L J Ransone; Inder M Verma
Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements.
Oncogene 1990;5(3):427-31.
1990: I Tratner; P De Togni; P Sassone-Corsi; Inder M Verma
Characterization and purification of human fos protein generated in insect cells with a baculoviral expression vector.
Journal of virology 1990;64(2):499-508.
1990: V J Dwarki; M Montminy; Inder M Verma
Both the basic region and the 'leucine zipper' domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation.
The EMBO journal 1990;9(1):225-32.
1990: Mark S Kindy; Inder M Verma
Developmental expression of the Xenopus laevis fos protooncogene.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(1):27-37.
1990: L J Ransone; Inder M Verma
Nuclear proto-oncogenes fos and jun.
Annual review of cell biology 1990;6():539-57.
1990: Inder M Verma; L J Ransone; J Visvader; P Sassone-Corsi; W W Lamph
fos-jun conspiracy: implications for the cell.
Ciba Foundation symposium 1990;150():128-37; discussion 137-46.
1990: J A Atwater; R Wisdom; Inder M Verma
Regulated mRNA stability.
Annual review of genetics 1990;24():519-41.
1989: Dinko Valerio; Mark Einerhand; P M Wamsley; T A Bakx; C L Li; Inder M Verma
Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeat.
Gene 1989;84(2):419-27.
1989: P Bull; Tony Hunter; Inder M Verma
Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts.
Molecular and cellular biology 1989;9(11):5239-43.
1989: R W Malone; P L Felgner; Inder M Verma
Cationic liposome-mediated RNA transfection.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(16):6077-81.
1989: P Sassone-Corsi; Channing J Der; Inder M Verma
ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun.
Molecular and cellular biology 1989;9(8):3174-83.
1989: L J Ransone; Inder M Verma
Association of nuclear oncoproteins fos and jun.
Current opinion in cell biology 1989;1(3):536-40.
1989: L J Ransone; J Visvader; P Sassone-Corsi; Inder M Verma
Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins.
Genes & development 1989;3(6):770-81.
1989: M Fujii; D Shalloway; Inder M Verma
Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos.
Molecular and cellular biology 1989;9(6):2493-9.
1989: J Visvader; Inder M Verma
Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.
Molecular and cellular biology 1989;9(3):1336-41.
1989: Inder M Verma; L J Ransone; J Visvader; P Sassone-Corsi; W W Lamph
fos-jun Conspiracy: implications for the cell.
Princess Takamatsu symposia 1989;20():119-26.
1989: L J Ransone; J Visvader; W W Lamph; P Sassone-Corsi; Inder M Verma
fos and jun interaction: the role of the leucine zipper.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1989;4():10-21.
1989: V Raymond; J A Atwater; Inder M Verma
Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos.
Oncogene research 1989;5(1):1-12.
1988: P Sassone-Corsi; L J Ransone; W W Lamph; Inder M Verma
Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.
Nature 1988;336(6200):692-5.
1988: P Sassone-Corsi; J Visvader; L Ferland; P L Mellon; Inder M Verma
Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element.
Genes & development 1988;2(12A):1529-38.
1988: J Visvader; P Sassone-Corsi; Inder M Verma
Two adjacent promoter elements mediate nerve growth factor activation of the c-fos gene and bind distinct nuclear complexes.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9474-8.
1988: M Fujii; P Sassone-Corsi; Inder M Verma
c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(22):8526-30.
1988: W W Lamph; P Wamsley; P Sassone-Corsi; Inder M Verma
Induction of proto-oncogene JUN/AP-1 by serum and TPA.
Nature 1988;334(6183):629-31.
1988: P Sassone-Corsi; W W Lamph; M Kamps; Inder M Verma
fos-associated cellular p39 is related to nuclear transcription factor AP-1.
Cell 1988;54(4):553-60.
1988: P Sassone-Corsi; J C Sisson; Inder M Verma
Transcriptional autoregulation of the proto-oncogene fos.
Nature 1988;334(6180):314-9.
1988: D St Louis; Inder M Verma
An alternative approach to somatic cell gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3150-4.
1988: P De Togni; H Niman; V Raymond; P Sawchenko; Inder M Verma
Detection of fos protein during osteogenesis by monoclonal antibodies.
Molecular and cellular biology 1988;8(5):2251-6.
1988: P Sassone-Corsi; W W Lamph; Inder M Verma
Regulation of proto-oncogene fos: a paradigm for early response genes.
Cold Spring Harbor symposia on quantitative biology 1988;53 Pt 2():749-60.
1988: J R Barber; P Sassone-Corsi; Inder M Verma
Proto-oncogene fos expression and post-translational modification.
Progress in clinical and biological research 1988;266():23-37.
1987: Inder M Verma; P Sassone-Corsi
Proto-oncogene fos: complex but versatile regulation.
Cell 1987;51(4):513-4.
1987: J R Barber; Inder M Verma
Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
Molecular and cellular biology 1987;7(6):2201-11.
1987: P Sassone-Corsi; Inder M Verma
Modulation of c-fos gene transcription by negative and positive cellular factors.
Nature 1987;326(6112):507-10.
1987: Nils Billestrup; R L Mitchell; Wylie Vale; Inder M Verma
Growth hormone-releasing factor induces c-fos expression in cultured primary pituitary cells.
Molecular endocrinology (Baltimore, Md.) 1987;1(4):300-5.
1987: D S Anson; R A Hock; D Austen; Kenneth J Smith; G G Brownlee; Inder M Verma; A D Miller
Towards gene therapy for hemophilia B.
Molecular biology & medicine 1987;4(1):11-20.
1987: R S McIvor; M J Johnson; A D Miller; S Pitts; S R Williams; D Valerio; D W Martin; Inder M Verma
Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses.
Molecular and cellular biology 1987;7(2):838-46.
1987: C Van Beveren; R L Mitchell; C Henning-Chubb; Eliezer Huberman; Inder M Verma
Expression of the c-fos gene during differentiation.
Advances in experimental medicine and biology 1987;213():263-74.
1987: J R Barber; P Sassone-Corsi; Inder M Verma
Proto-oncogene fos: factors affecting expression and covalent modification of the gene product.
Annals of the New York Academy of Sciences 1987;511():117-30.
1987: Inder M Verma; W R Graham
The fos oncogene.
Advances in cancer research 1987;49():29-52.
1986: Wiebe Kruijer; H Skelly; F Botteri; Herman van der Putten; J R Barber; Inder M Verma; Hyam L Leffert
Proto-oncogene expression in regenerating liver is simulated in cultures of primary adult rat hepatocytes.
The Journal of biological chemistry 1986;261(17):7929-33.
1986: R L Mitchell; C Henning-Chubb; E Huberman; Inder M Verma
c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages.
Cell 1986;45(4):497-504.
1986: L Coussens; C Van Beveren; D Smith; E Chen; R L Mitchell; C M Isacke; Inder M Verma; A Ullrich
Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
Nature 1986;320(6059):277-80.
1986: E Chen; L Coussens; Y C Liao; D Smith; T L Yang-Feng; J McGrath; C Van Beveren; Inder M Verma; Towia Libermann; J Schlessinger
Structural features of growth factor receptors with oncogenic potential.
Biochemical Society symposium 1986;52():65-82.
1986: Inder M Verma; J Deschamps; C Van Beveren; P Sassone-Corsi
Human fos gene.
Cold Spring Harbor symposia on quantitative biology 1986;51 Pt 2():949-58.
1986: F M Botteri; Herman van der Putten; A D Miller; H Fan; Inder M Verma
Recombinant retroviruses in transgenic mice.
Annals of the New York Academy of Sciences 1986;478():255-68.
1986: Inder M Verma; R L Mitchell; P Sassone-Corsi
Proto-oncogene fos: an inducible gene.
Princess Takamatsu symposia 1986;17():279-90.
1986: C Van Beveren; Inder M Verma
Homology among oncogenes.
Current topics in microbiology and immunology 1986;123():73-98.
1986: R L Mitchell; S K Hanks; Inder M Verma
Proto-oncogene fos: an inducible multifaceted gene.
Symposium on Fundamental Cancer Research 1986;39():99-113.
1985: Jacqueline Deschamps; Frits Meijlink; Inder M Verma
Identification of a transcriptional enhancer element upstream from the proto-oncogene fos.
Science (New York, N.Y.) 1985;230(4730):1174-7.
1985: Wiebe Kruijer; David Schubert; Inder M Verma
Induction of the proto-oncogene fos by nerve growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(21):7330-4.
1985: Herman van der Putten; F M Botteri; A D Miller; M G Rosenfeld; H Fan; R M Evans; Inder M Verma
Efficient insertion of genes into the mouse germ line via retroviral vectors.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(18):6148-52.
1985: A D Miller; Inder M Verma; T Curran
Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity.
Journal of virology 1985;55(3):521-6.
1985: F Meijlink; T Curran; A D Miller; Inder M Verma
Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(15):4987-91.
1985: A D Miller; M F Law; Inder M Verma
Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.
Molecular and cellular biology 1985;5(3):431-7.
1985: T Curran; C Van Beveren; Inder M Verma
Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein.
Molecular and cellular biology 1985;5(1):167-72.
1985: R L Mitchell; L Zokas; R D Schreiber; Inder M Verma
Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation.
Cell 1985;40(1):209-17.
1985: Jacqueline Deschamps; R L Mitchell; Frits Meijlink; Wiebe Kruijer; David Schubert; Inder M Verma
Proto-oncogene fos is expressed during development, differentiation, and growth.
Cold Spring Harbor symposia on quantitative biology 1985;50():733-45.
1984: Wiebe Kruijer; J A Cooper; Tony Hunter; Inder M Verma
Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein.
Nature 1984;312(5996):711-6.
1984: B H Cochran; J Zullo; Inder M Verma; Charles D Stiles
Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor.
Science (New York, N.Y.) 1984;226(4678):1080-2.
1984: A D Miller; E S Ong; M G Rosenfeld; Inder M Verma; R M Evans
Infectious and selectable retrovirus containing an inducible rat growth hormone minigene.
Science (New York, N.Y.) 1984;225(4666):993-8.
1984: Peter Barker; M Rabin; M Watson; W R Breg; F H Ruddle; Inder M Verma
Human c-fos oncogene mapped within chromosomal region 14q21----q31.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(18):5826-30.
1984: A D Miller; R J Eckner; D J Jolly; T Friedmann; Inder M Verma
Expression of a retrovirus encoding human HPRT in mice.
Science (New York, N.Y.) 1984;225(4662):630-2.
1984: C R Lin; W S Chen; W Kruiger; L S Stolarsky; W Weber; R M Evans; Inder M Verma; G N Gill; M G Rosenfeld
Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells.
Science (New York, N.Y.) 1984;224(4651):843-8.
1984: C Van Beveren; S Enami; T Curran; Inder M Verma
FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes.
Virology 1984;135(1):229-43.
1984: T Curran; Inder M Verma
FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product.
Virology 1984;135(1):218-28.
1984: Dennis J Slamon; J B deKernion; Inder M Verma; M J Cline
Expression of cellular oncogenes in human malignancies.
Science (New York, N.Y.) 1984;224(4646):256-62.
1984: Inder M Verma
From c-fos to v-fos.
Nature 1984;308(5957):317.
1984: T Curran; A D Miller; L Zokas; Inder M Verma
Viral and cellular fos proteins: a comparative analysis.
Cell 1984;36(2):259-68.
1984: A D Miller; T Curran; Inder M Verma
c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene.
Cell 1984;36(1):51-60.
1984: R Müller; Inder M Verma
Expression of cellular oncogenes.
Current topics in microbiology and immunology 1984;112():73-115.
1984: A D Miller; Inder M Verma
Two base changes restore infectivity to a noninfectious molecular clone of Moloney murine leukemia virus (pMLV-1).
Journal of virology 1984;49(1):214-22.
1983: W P MacConnell; Inder M Verma
Expression of FBJ-MSV oncogene (fos) product in bacteria.
Virology 1983;131(2):367-74.
1983: R Müller; J M Tremblay; E D Adamson; Inder M Verma
Tissue and cell type-specific expression of two human c-onc genes.
Nature 1983;304(5925):454-6.
1983: A D Miller; D J Jolly; T Friedmann; Inder M Verma
A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(15):4709-13.
1983: F van Straaten; R Müller; T Curran; C Van Beveren; Inder M Verma
Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(11):3183-7.
1983: R Müller; Dennis J Slamon; E D Adamson; J M Tremblay; D Müller; M J Cline; Inder M Verma
Transcription of c-onc genes c-rasKi and c-fms during mouse development.
Molecular and cellular biology 1983;3(6):1062-9.
1983: T Curran; W P MacConnell; F van Straaten; Inder M Verma
Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells.
Molecular and cellular biology 1983;3(5):914-21.
1983: C Van Beveren; F van Straaten; T Curran; R Müller; Inder M Verma
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.
Cell 1983;32(4):1241-55.
1983: Douglas J Jolly; A C Esty; S Subramani; T Friedmann; Inder M Verma
Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene.
Nucleic acids research 1983;11(6):1855-72.
1983: R Müller; Inder M Verma; E D Adamson
Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion.
The EMBO journal 1983;2(5):679-84.
1982: T Curran; G Peters; C Van Beveren; N M Teich; Inder M Verma
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.
Journal of virology 1982;44(2):674-82.
1982: R Müller; Dennis J Slamon; J M Tremblay; M J Cline; Inder M Verma
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.
Nature 1982;299(5884):640-4.
1982: R A Bosselman; F van Straaten; C Van Beveren; Inder M Verma; M Vogt
Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA.
Journal of virology 1982;44(1):19-31.
1982: J Papkoff; Inder M Verma; Tony Hunter
Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.
Cell 1982;29(2):417-26.
1982: J Doehmer; M Barinaga; W Vale; M G Rosenfeld; Inder M Verma; R M Evans
Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(7):2268-72.
1982: C Van Beveren; E Rands; S K Chattopadhyay; Douglas Lowy; Inder M Verma
Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.
Journal of virology 1982;41(2):542-56.
1982: H van der Putten; W Quint; Inder M Verma; Anton Berns
Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.
Nucleic acids research 1982;10(2):577-92.
1981: J Papkoff; M H Lai; Tony Hunter; Inder M Verma
Analysis of transforming gene products from Moloney murine sarcoma virus.
Cell 1981;27(1 Pt 2):109-19.
1981: C Van Beveren; F van Straaten; J A Galleshaw; Inder M Verma
Nucleotide sequence of the genome of a murine sarcoma virus.
Cell 1981;27(1 Pt 2):97-108.
1981: S A Fuhrman; C Van Beveren; Inder M Verma
Identification of a RNA polymerase II initiation site in the long terminal repeat of Moloney murine leukemia viral DNA.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(9):5411-5.
1981: H van der Putten; W Quint; J van Raaij; E R Maandag; Inder M Verma; Anton Berns
M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors.
Cell 1981;24(3):729-39.
1981: C Van Beveren; J G Goddard; A J Berns; Inder M Verma
Biogenesis of a transforming gene.
Molecular biology reports 1981;7(1-3):163-5.
1981: C Van Beveren; J A Galleshaw; V Jonas; A J Berns; R F Doolittle; D J Donoghue; Inder M Verma
Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus.
Nature 1981;289(5795):258-62.
1980: A J Berns; M H Lai; R A Bosselman; M A McKennett; Lee Bacheler; H Fan; E C Maandag; H V van der Putten; Inder M Verma
Molecular cloning of unintegrated and a portion of integrated moloney murine leukemia viral DNA in bacteriophage lambda.
Journal of virology 1980;36(1):254-63.
1980: M H Lai; Inder M Verma
Genome organization of retroviruses. VIII. Nonproducer cell lines of mouse fibroblasts transformed by Moloney murine sarcoma virus DNA synthesized in vitro.
Virology 1980;104(2):407-17.
1980: C Van Beveren; J G Goddard; A Berns; Inder M Verma
Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3307-11.
1980: J G Sutcliffe; T M Shinnick; Inder M Verma; R A Lerner
Nucleotide sequence of Moloney leukemia virus: 3' end reveals details of replications, analogy to bacterial transposons, and an unexpected gene.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3302-6.
1980: M Jones; R A Bosselman; F A van der Hoorn; A Berns; H Fan; Inder M Verma
Identification and molecular cloning of Moloney mouse sarcoma virus-specific sequences from uninfected mouse cells.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(5):2651-5.
1980: R A Bosselman; Leo van Griensven; M Vogt; Inder M Verma
Genome organization of retroviruses IX. Analysis of the genomes of Friend spleen focus-forming (F-SFFV) and helper murine leukemia viruses by heteroduplex-formation.
Virology 1980;102(1):234-9.
1980: Inder M Verma; M H Lai; R A Bosselman; M A McKennett; H Fan; A Berns
Molecular cloning of unintegrated Moloney mouse sarcoma virus DNA in bacteriophage lambda.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(4):1773-7.
1980: M H Lai; Inder M Verma
Genome organization of retroviruses. VII. Infection by double-stranded DNA synthesized in vitro from Moloney murine leukemia virus generates a virus indistinguishable from the original virus used in reverse transcription.
Virology 1980;100(1):194-8.
1980: R A Bosselman; Inder M Verma
Genome organization of retroviruses. V. In vitro-synthesized Moloney murine leukemia viral DNA has long terminal redundancy.
Journal of virology 1980;33(1):487-93.
1980: J G Sutcliffe; T M Shinnick; R A Lerner; P Johnson; Inder M Verma
Nucleotide sequence of a cloned murine leukemia virus DNA fragment.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 2,():1275-9.
1979: R A Bosselman; Leo van Griensven; M Vogt; Inder M Verma
Genome organization of retroviruses. VI. Heteroduplex analysis of ecotropic and xenotropic sequences of moloney mink cell focus-inducing viral RNA obtained from either a cloned isolate or a thymoma cell line.
Journal of virology 1979;32(3):968-78.
1979: Y H Chien; Inder M Verma; P H Duesberg; N Davidson
Heteroduplex analysis of the RNA of clone 3 Moloney murine sarcoma virus.
Journal of virology 1979;32(3):1028-32.
1979: U H Chien; M Lai; T Y Shih; Inder M Verma; E M Scolnick; P Roy-Burman; N Davidson
Heteroduplex analysis of the sequence relationships between the genomes of Kirsten and Harvey sarcoma viruses, their respective parental murine leukemia viruses, and the rat endogenous 30S RNA.
Journal of virology 1979;31(3):752-60.
1979: Inder M Verma
Genome organization of retroviruses. III. Restriction endonuclease cleavage maps of mouse sarcoma virus double-stranded DNA synthesized in vitro.
Nucleic acids research 1979;6(5):1863-7.
1978: Y H Chien; Inder M Verma; T Y Shih; E M Scolnick; N Davidson
Heteroduplex analysis of the sequence relations between the RNAs of mink cell focus-inducing and murine leukemia viruses.
Journal of virology 1978;28(1):352-60.
1978: M H Lai; Inder M Verma; S R Tronick; S A Aaronson
Mammalian retrovirus-associated RNase H is virus coded.
Journal of virology 1978;27(3):823-5.
1978: Inder M Verma; M A McKennett
Genome organization of RNA tumor viruses II. Physical maps of in vitro-synthesized Moloney murine leukemia virus double-stranded DNA by restriction endonucleases.
Journal of virology 1978;26(3):630-45.
1978: Inder M Verma
Genome organization of RNA tumor viruses. I. In vitro synthesis of full-genome-length single-stranded and double-stranded viral DNA transcripts.
Journal of virology 1978;26(3):615-29.
1978: H Fan; Inder M Verma
Size analysis and relationship of murine leukemia virus-specific mRNA's: evidence for transposition of sequences during synthesis and processing of subgenomic mRNA.
Journal of virology 1978;26(2):468-78.
1978: M H Lai; Inder M Verma
Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity.
Journal of virology 1978;25(2):652-63.
1977: Inder M Verma
The reverse transcriptase.
Biochimica et biophysica acta 1977;473(1):1-38.
1976: Inder M Verma; Harold Varmus; Eric Hunter
Characterization of "early" temperature-sensitive mutants of avian sarcoma viruses: biological properties, thermolability of reverse transcriptase in vitro, and synthesis of viral DNA in infected cells.
Virology 1976;74(1):16-29.
1975: S R Tronick; J R Stephenson; Inder M Verma; S A Aaronson
Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions.
Journal of virology 1975;16(6):1476-82.
1975: Inder M Verma; Eric Hunter
Reverse transcriptase is coded for by the viral RNA.
Bibliotheca haematologica 1975;(43):457-9.
1975: Inder M Verma
Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.
Journal of virology 1975;15(4):843-54.
1975: A Panet; Inder M Verma; David Baltimore
Role of the subunits of the avian RNA tumor virus reverse transcriptase.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 2():919-23.
1975: Inder M Verma
Studies on reverse transcriptase of RNA tumor viruses. I. Localization of thermolabile DNA polymerase and RNase H activities on one polypeptide.
Journal of virology 1975;15(1):121-6.
1974: D GIBSON; Inder M Verma
Studies on the reverse transcriptase of RNA tumor viruses. Structural relatedness of two subunits of avian RNA tumor viruses.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(12):4991-4.
1974: B G Forget; C A Marotta; S M Weissman; Inder M Verma; R P McCaffrey; David Baltimore
Nucleotide sequences of human globin messenger RNA.
Annals of the New York Academy of Sciences 1974;241(0):290-309.
1974: David Baltimore; Inder M Verma; S Drost; W S Mason
Temperature-sensitive DNA polymerase from Rous sarcoma virus mutants.
Cancer 1974;34(4 Suppl):suppl:1395-7.
1974: Inder M Verma; R A Firtel; Harvey Lodish; David Baltimore
Synthesis of DNA complementary to cellular slime mold messenger RNA by reverse transcriptase.
Biochemistry 1974;13(19):3917-22.
1974: Inder M Verma; W S Mason; S D Drost; David Baltimore
DNA polymerase activity from two temperature-sensitive mutants of Rous sarcoma virus is thermolabile.
Nature 1974;251(5470):27-31.
1974: C A Marotta; B G Forget; S M Weissman; Inder M Verma; R P McCaffrey; David Baltimore
Nucleotide sequences of human globin messenger RNA.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(6):2300-4.
1974: Inder M Verma; N L Meuth; H Fan; David Baltimore
Hamster leukemia virus: lack of endogenous DNA synthesis and unique structure of its DNA polymerase.
Journal of virology 1974;13(5):1075-82.
1974: B G Forget; David Baltimore; E J Benz; D Housman; P Lebowitz; C A Marotta; R P McCaffrey; Arthur I Skoultchi; Paul Steven Swerdlow; Inder M Verma; S M Weissman
Globin messenger RNA in the thalassemia syndromes.
Annals of the New York Academy of Sciences 1974;232(0):76-87.
1974: Inder M Verma; David Baltimore
Purification of the RNA-directed DNA polymerase from avian myeloblastosis virus and its assay with polynucleotide templates.
Methods in enzymology 1974;29():125-30.
1973: A J Berns; H Bloemendal; S J Kaufman; Inder M Verma
Synthesis of DNA complementary to 14S calf lens crystallin messenger RNA by reverse transcriptase.
Biochemical and biophysical research communications 1973;52(3):1013-9.
1973: David Baltimore; Inder M Verma; D F Smoler; N L Meuth
Avian myeloblastosis virus DNA polymerase: initiation of DNA synthesis and an associated ribonuclease.
Johns Hopkins medical journal. Supplement 1973;2():193-8.
1972: Inder M Verma; G F Temple; H Fan; David Baltimore
In vitro synthesis of DNA complementary to rabbit reticulocyte 10S RNA.
Nature: New biology 1972;235(58):163-7.
1971: Inder M Verma; N L Meuth; E Bromfeld; K F Manly; David Baltimore
Covalently linked RNA-DNA molecule as initial product of RNA tumour virus DNA polymerase.
Nature: New biology 1971;233(39):131-4.
1971: M Edelman; Inder M Verma; R Herzog; E Galun; U Z Littauer
Physico-chemical properties of mitochondrial ribosomal RNA from fungi.
European journal of biochemistry / FEBS 1971;19(3):372-8.
1971: Inder M Verma; M Edelman; U Z Littauer
A comparison of nucleotide sequences from mitochondrial and cytoplasmic ribosomal RNA of Aspergillus nidulans.
European journal of biochemistry / FEBS 1971;19(1):124-9.
1971: M Edelman; Inder M Verma; D Saya; U Z Littauer
Optical absorbance properties of mitochondrial ribosomal RNA.
Biochemical and biophysical research communications 1971;42(2):208-13.
1970: Inder M Verma; M Edelman; M Herzberg; U Z Littauer
Size determination of mitochondrial ribosomal RNA from Aspergillus nidulans by electron microscopy.
Journal of molecular biology 1970;52(1):137-40.
1970: M Edelman; Inder M Verma; U Z Littauer
Mitochondrial ribosomal RNA from Aspergillus nidulans: characterization of a novel molecular species.
Journal of molecular biology 1970;49(1):67-83.